A previous study indicated that encorafenib administration stimulates TRAIL-induced apoptosis of colorectal cancer cells via p53/PUMA signaling [18]; however, the precise molecular mechanism underlying the effect of cisatracurium besilate on TRAIL-induced apoptosis of AGS cells is not completely understood. The gene discussed is TP53; the disease is colorectal cancer.